Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

British Journal of Cancer

Volumn 106, Issue 5, 2012, Pages 923-930

  Kwon, M J ^a,f   Park, S ^b   Choi, J Y ^c   Oh, E ^c   Kim, Y J ^d   Park, Y H ^e   Cho, E Y ^e   Nam, S J ^e   Im, Y H ^e   Shin, Y K ^a,c   Choi, Y L ^d,e  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Seoul National University   (South Korea)

^d Samsung Medical Center   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f Hallym University College of Medicine   (South Korea)

Author keywords

breast cancer; CD151; five subtypes; prognosis; tetraspanin

Indexed keywords

CD151 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BREAST CANCER; CANCER SIZE; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUINTUPLE NEGATIVE BREAST CANCER; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD151; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862811077     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.11     Document Type: Article

References (32)

1. Ang J, Fang BL, Ashman LK, Frauman AG (2010) The migration and invasion of human prostate cancer cell lines involves CD151 expression. Oncol Rep 24(6): 1593-1597
2. Ang J, Lijovic M, Ashman LK, Kan K, Frauman AG (2004) CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator? Cancer Epidemiol Biomarkers Prev 13(11 Pt 1): 1717-1721 (Pubitemid 39482947)
3. Chien CW, Lin SC, Lai YY, Lin BW, Lee JC, Tsai SJ (2008) Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer. Clin Cancer Res 14(24): 8043-8051
4. Choi YL, Oh E, Park S, Kim Y, Park YH, Song K, Cho EY, Hong YC, Choi JS, Lee JE, Kim JH, Nam SJ, Im YH, Yang JH, Shin YK (2010) Triplenegative, basal-like, and quintuple-negative breast cancers: better prediction model for survival. BMC Cancer 10: 507
5. Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, Giancotti FG (2006) Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126(3): 489-502 (Pubitemid 44163602)
6. Hashida H, Takabayashi A, Tokuhara T, Hattori N, Taki T, Hasegawa H, Satoh S, Kobayashi N, Yamaoka Y, Miyake M (2003) Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer 89(1): 158-167 (Pubitemid 36897952)
7. Hemler ME (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6(10): 801-811 (Pubitemid 41726118)
8. Hemler ME (2008) Targeting of tetraspanin proteins-potential benefits and strategies. Nat Rev Drug Discov 7(9): 747-758
9. Huang XY, Ke AW, Shi GM, Ding ZB, Devbhandari RP, Gu FM, Li QL, Dai Z, Zhou J, Fan J (2010) Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer 116(23): 5440-5451
10. Ke AW, Shi GM, Zhou J, Huang XY, Shi YH, Ding ZB, Wang XY, Devbhandari RP, Fan J (2011) CD151 amplifies signaling by integrin alpha6beta1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology 140(5): 1629-1641e15
11. Ke AW, Shi GM, Zhou J, Wu FZ, Ding ZB, Hu MY, Xu Y, Song ZJ, Wang ZJ, Wu JC, Bai DS, Li JC, Liu KD, Fan J (2009) Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 49(2): 491-503
12. Kohno M, Hasegawa H, Miyake M, Yamamoto T, Fujita S (2002) CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 97(3): 336-343 (Pubitemid 34049024)
13. Maecker HT, Todd SC, Levy S (1997) The tetraspanin superfamily: molecular facilitators. FASEB J 11(6): 428-442 (Pubitemid 27259984)
14. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93(4): 387-391 (Pubitemid 43080010)
15. Novitskaya V, Romanska H, Dawoud M, Jones JL, Berditchevski F (2010) Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ. Cancer Res 70(11): 4698-4708
16. Romanska HM, Berditchevski F (2011) Tetraspanins in human epithelial malignancies. J Pathol 223(1): 4-14
17. Sadej R, Romanska H, Baldwin G, Gkirtzimanaki K, Novitskaya V, Filer AD, Krcova Z, Kusinska R, Ehrmann J, Buckley CD, Kordek R, Potemski P, Eliopoulos AG, Lalani el N, Berditchevski F (2009) CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol Cancer Res 7(6): 787-798
18. Sadej R, Romanska H, Kavanagh D, Baldwin G, Takahashi T, Kalia N, Berditchevski F (2010) Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res 70(14): 6059-6070
19. Shaw LM, Rabinovitz I, Wang HH, Toker A, Mercurio AM (1997) Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 91(7): 949-960 (Pubitemid 28027828)
20. Sincock PM, Mayrhofer G, Ashman LK (1997) Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 45(4): 515-525 (Pubitemid 27175796)
21. Suzuki S, Miyazaki T, Tanaka N, Sakai M, Sano A, Inose T, Sohda M, Nakajima M, Kato H, Kuwano H (2010) Prognostic significance of CD151 expression in esophageal squamous cell carcinoma with aggressive cell proliferation and invasiveness. Ann Surg Oncol 18(3): 888-893
22. Testa JE, Brooks PC, Lin JM, Quigley JP (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59(15): 3812-3820 (Pubitemid 29381891)
23. Tokuhara T, Hasegawa H, Hattori N, Ishida H, Taki T, Tachibana S, Sasaki S, Miyake M (2001) Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin Cancer Res 7(12): 4109-4114 (Pubitemid 34044635)
24. Voss MA, Gordon N, Maloney S, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W, Berditchevski F, Sundar S (2011) Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer. Br J Cancer 104(10): 1611-1618
25. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1): 118-145 (Pubitemid 350003059)
26. Yang XH, Flores LM, Li Q, Zhou P, Xu F, Krop IE, Hemler ME (2010) Disruption of laminin-integrin-CD151-focal adhesion kinaseaxis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res 70(6): 2256-2263
27. Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, Kazarov AR, Andzelm MM, Strominger JL, Brown M, Hemler ME (2008) CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res 68(9): 3204-3213
28. Yoo SH, Lee K, Chae JY, Moon KC (2011) CD151 expression can predict cancer progression in clear cell renal cell carcinoma. Histopathology 58(2): 191-197
29. Zahir N, Lakins JN, Russell A, Ming W, Chatterjee C, Rozenberg GI, Marinkovich MP, Weaver VM (2003) Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 163(6): 1397-1407 (Pubitemid 38032099)
30. Zhu GH, Huang C, Qiu ZJ, Liu J, Zhang ZH, Zhao N, Feng ZZ, Lv XH (2011) Expression and prognostic significance of CD151, c-Met, and integrin alpha3/alpha6 in pancreatic ductal adenocarcinoma. Dig Dis Sci 56(4): 1090-1098
31. Zijlstra A, Lewis J, Degryse B, Stuhlmann H, Quigley JP (2008) The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 13(3): 221-234 (Pubitemid 351318371)
32. Zoller M (2009) Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 9(1): 40-55